MoonLake Immunotherapeutics - Class A (MLTX) Earnings Report - Forecasts and Surprise Ratio

Quarterly Earnings History

MLTX ratio: 55%

100%

MLTX beat 6 of 11 last estimates

Date of next report: Mar 6, 2025

Estimate for Q4 24: $-0.62

Implied change from Q3 24: +10.71%

Implied change from Q4 23: +416.67%

Earnings Period	Date Reported	EPS / Forecast	Surprise
Q3 24	Nov 7, 2024	$-0.56 / $-0.44	$-0.12 / -27.27%
Q2 24	Aug 7, 2024	$-0.39 / $-0.28	$-0.11 / -39.29%
Q1 24	May 7, 2024	$-0.22 / $-0.21	$-0.01 / -4.76%
Q4 23	Feb 29, 2024	$-0.12 / $-0.21	$0.09 / 42.86%
Q3 23	Nov 14, 2023	$-0.18 / $-0.22	$0.04 / 18.18%
Q2 23	Aug 10, 2023	$-0.23 / $-0.25	$0.02 / 8%
Q1 23	May 12, 2023	$-0.23 / $-0.28	$0.05 / 17.86%
Q4 22	Mar 20, 2023	$-0.31 / $-0.32	$0.01 / 3.12%

Data Vendor: Xignite Logo